NYT | Business Follow Moderna’s Shift to Cancer Company Lifts Stock Up 177% The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else. https://www.nytimes.com/2026/08/20/business/moderna-cancer-melanoma.html nytimes.com
